Pentokey Organy (India) Ltd Share Price

Pentokey Organy
Small Cap | Pharmaceuticals
₹ 45 -1.32 (-2.85%)
Last updated: 26-Dec-2025 , 14:26:24

Pentokey Organy (India) Ltd Live Price Chart

Low: ₹45 High: 45

Pentokey Organy (India) Ltd Technicals

Current Price
₹ 45 -1.32 (-2.85%)
EMASMA
20 Day ₹ 46.527
50 Day ₹ 47.276
100 Day ₹ 46.462
200 Day ₹ 45.983
20 Day ₹ 46.663
50 Day ₹ 48.579
100 Day ₹ 46.248
200 Day ₹ 43.624

Pentokey Organy (India) Ltd Performance

Previous Close ₹ 46.32
High ₹ 45
Volume 462
52W Range ₹ 27.5 - ₹ 63.99
Open ₹ 45
Low ₹ 45
Market Cap 32.74 Cr

Pentokey Organy (India) Ltd Fundamentals

ROCE 7.059
P/E Ratio 40.280
P/B Ratio 2.840
Industry P/E 2.840
Debt to Equity 40.152
ROE 7.058
EPS 1.150
Dividend Yield 0.000
Book Value 16.293
Face Value 10.000

Pentokey Organy (India) Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 1.2905 4.8477 6.7215 0.2519 0.2997881
Total Expenses 1.045 3.9723 3.546 0.4154 0.5403963
Profit After Tax 0.2455 0.8754 3.1755 -0.1635 -0.2406082

Pentokey Organy (India) Ltd Shareholding Pattern

Promoter Holdings 73.035 %
FIIs 0.000 %
DIIs 2.245 %
MutualFund 0.064 %
Retail 16.312 %
Others - 8.345 %

About Pentokey Organy (India) Ltd

History of Pentokey Organy (India) Ltd

Pentokey Organy (India) Ltd was incorporated on November 26, 1986. The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde. Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices. Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde. As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low. Acetaldehyde was produced only to the extent of demand from customers. Further, Company ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Cipla Ltd ₹ 1335 - ₹ 1673 1508 22.23
J B Chemicals & Pharmaceuticals Ltd ₹ 1385.75 - ₹ 1918.5 1816.65 40.35
Unichem Laboratories Ltd ₹ 432.05 - ₹ 790.7 444.5 55.71
Lyka Labs Ltd ₹ 72.2 - ₹ 167.19 74.7 227.42
Dr Reddys Laboratories Ltd ₹ 1020 - ₹ 1405.9 1266.65 19.58

FAQs on Pentokey Organy (India) Ltd

1. Can I buy Pentokey Organy (India) Ltd from PL Capital? ›

Yes, you can invest in Pentokey Organy (India) Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Pentokey Organy (India) Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Pentokey Organy (India) Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Pentokey Organy (India) Ltd pay dividends? ›

Pentokey Organy (India) Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Pentokey Organy (India) Ltd ? ›

As of 24-12-2025 the share price for Pentokey Organy (India) Ltd. is 46.32 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Pentokey Organy (India) Ltd ? ›

The 52-week high and low of Pentokey Organy (India) Ltd share price is ₹ 27.5 - ₹ 63.99 as of 24-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source